In the aftermath of the enactment of the America Invents Act, the Preserve Access to Affordable Generics Act (112 S.27), introduced in 2011,  is receiving a lot of interest from the pharmaceutical industry over its intellectual property provisions.  Here is a quick look at the people and organizations with significant interests in this bill. Quick […]